Table 2.
Initial findings on CMR
| LVEF at diagnosis, % | 57.0 ± 9.0 |
| LVEDV at diagnosis, ml/m2 | 72.9 ± 18.0 |
| Patients with pericardial effusion (N,%) | 58 (28.4) |
| Patients with asynergic myocardial segments (N,%) | 39 (19) |
| LGE | |
| Number of patients with LGE (N,%) | 203 (100) |
| Number of segments with LGE, N | 3.8 ± 2.2 |
| Myocardial extent of LGE (% myocardial surface area) | 11.4 ± 7.0 |
| Nodular Pattern (N,%) | 150 (73.5) |
| Sub-epicardial lesions (N,%) | 168 (82.3) |
| Midwall lesions (N,%) | 33 (16.1) |
| Transmural lesions (N,%) | 2 (1.0) |
| Presence of LGE in opposed walls (N,%) | 77 (38.0) |
| Postero-lateral localization (N,%) | 122 (60) |
| Anterior wall involved (N,%) | 17 (8.3) |
| Postero-lateral and septal localisation (N,%) | 60 (29.4) |
| Hyper T2 signal | |
| Number of patients with hyper T2 (N,%) | 100 (62.5) |
| Number of segments with hyper T2 signal | 1.9 ± 1.8 |
| Myocardial extent of Hyper T2 (% myocardial surface area) | 10.9 ± 5.7 |
| Presence of T2 hyper-signal in opposed walls (N,%) | 34 (21.2) |
| EGE | |
| Number of patients with EGE (N,%) | 114 (56) |
| Number of segments with EGE | 1.8 ± 1.9 |
| Myocardial extent of EGE (% myocardial surface area) | 8.6 ± 5.4 |
| Presence of local EGE in opposed walls (N,%) | 30 (14.7) |
Values are expressed as mean ± SD unless specified